616073273	616073273	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
32035293	32035293	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
681980	681980	CD	B-NP	O
|	|	CC	I-NP	O
6/3/1999	6/3/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/3/1999	6/3/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/3/1999	5/3/1999	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64	64	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
at	at	IN	B-PP	O
Ryhoagberg	Ryhoagberg	NNP	B-NP	O
Spisus	Spisus	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
tapering	taper	VBG	I-NP	O
lesion	lesion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
distal	distal	JJ	B-ADJP	O
to	to	TO	B-PP	O
D1	D1	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Psoriasis	Psoriasis	NN	B-NP	O
and	and	CC	I-NP	O
polymyalgia	polymyalgia	NN	I-NP	O
rheumatica	rheumatica	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
wide	wide	JJ	B-NP	O
eye	eye	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
45	45	CD	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Prednisone	Prednisone	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Zocor	Zocor	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Nitropatch	Nitropatch	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Enteric	Enteric	JJ	I-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Timolol	Timolol	NN	I-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Captopril	Captopril	NNP	I-NP	O
18.75	18.75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Tagamet	Tagamet	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Calcium	Calcium	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8.8	8.8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
40.2	40.2	CD	I-NP	I-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
On	On	NNP	B-NP	O
May	May	NNP	I-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
intraoperative	intraoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
one	one	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
extubation	extubation	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
stress	stress	NN	B-NP	O
steroids	steroid	NNS	I-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
steroid	steroid	NN	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
one	one	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
bleeding	bleed	VBG	B-NP	O
.	.	.	O	O

After	After	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
reintubated	reintubate	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
and	and	CC	I-NP	O
stable	stable	JJ	I-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
intensive	intensive	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
on	on	IN	B-PP	O
renal	renal	JJ	B-NP	O
Dopamine	Dopamine	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
extubated	extubate	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
consultation	consultation	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
since	since	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
clot	clot	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
transesophageal	transesophageal	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
probe	probe	NN	I-NP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
saw	see	VBD	B-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
upper	upper	JJ	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
H2	H2	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
step	step	NN	I-NP	O
down	down	RP	B-PRT	O
unit	unit	NN	B-NP	O
on	on	IN	B-PP	O
routine	routine	JJ	B-NP	O
postoperative	postoperative	JJ	I-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
two	two	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Captopril	Captopril	NNP	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
for	for	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
course	course	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
still	still	RB	B-ADVP	O
requiring	require	VBG	B-VP	O
oxygen	oxygen	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
91	91	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
three	three	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
care	care	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
situation	situation	NN	I-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
and	and	CC	I-NP	O
ambulation	ambulation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
by	by	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
and	and	CC	O	O
awaited	await	VBD	B-VP	O
rehabilitation	rehabilitation	NN	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
acquire	acquire	VB	I-VP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
bed	bed	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
six	six	CD	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Prednisone	Prednisone	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Enteric	Enteric	JJ	I-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Zantac	Zantac	NN	I-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atrovent	Atrovent	NNP	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Timolol	Timolol	NN	I-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
eyes	eye	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Captopril	Captopril	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Lasix	Lasix	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Potassium	Potassium	NNP	I-NP	O
SR	SR	NNP	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
-RRB-	-RRB-	:	O	O
Simvastatin	Simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Ibuprofen	Ibuprofen	NN	I-NP	O
200-800	200-800	CD	I-NP	O
mg	mg	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lou	Lou	NNP	I-NP	O
Pineault	Pineault	NNP	I-NP	O
at	at	IN	B-PP	O
Potmend	Potmend	NNP	B-NP	O
Rehabilitation	Rehabilitation	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
Moorlberl	Moorlberl	NNP	B-NP	O
Street	Street	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RENE	RENE	NNP	B-NP	O
CASTLEMAN	CASTLEMAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ERIN	ERIN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
CURTISS	CURTISS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OA44	OA44	NNP	I-NP	O
BU596/3851	BU596/3851	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
4743	4743	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

ILIU083L6I	ILIU083L6I	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/10/99	11/10/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/10/99	11/10/99	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
STEPHEN	STEPHEN	NNP	B-NP	O
T.	T.	NNP	I-NP	O
SHIMANUKI	SHIMANUKI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CK7	CK7	NNP	I-NP	O
DUSTY	DUSTY	NNP	I-NP	O
BJORGEN	BJORGEN	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
ON-TONFORN	ON-TONFORN	NNP	B-NP	O

